Predicting the long-term clinical effectiveness of daclizumab in relapsing-remitting multiple sclerosis- A new modeling framework using discrete event simulation
Abstract
Authors
S. Guo L. Hernandez C. Saint-Laurent Thibault I. Proskorovsky G.A. Phillips